NCI Unveils Nanotech Initiative, Looks To Award Molecular Imaging Grants
This article was originally published in The Gray Sheet
Executive Summary
Molecular imaging and early detection grants will be awarded by the National Cancer Institute as part of a broader $144.3 mil. nanotechnology initiative announced Sept. 13
You may also be interested in...
FDA Inks Nanotech Agreement With Cancer And Standards Institutes
FDA collaboration in the nanotechnology field with two other federal agencies may serve to facilitate premarket reviews for nanotech-based cancer diagnostics and therapeutics
FDA Inks Nanotech Agreement With Cancer And Standards Institutes
FDA collaboration in the nanotechnology field with two other federal agencies may serve to facilitate premarket reviews for nanotech-based cancer diagnostics and therapeutics
FDA Science Board Previews Device “Critical Path” R&D Opportunity List
Peripheral vasculature imaging is poised to be an early beneficiary of FDA's "critical path" initiative, CDRH Office of Science & Engineering Director Larry Kessler told the agency's Science Board April 22